Development of effective immunotherapy for triple negative breast cancer by WEE1 kinase inhibition

被引：0
|
作者：
Choi, Mi Ran [1 ]
Xie, Ping [1 ]
Tang, Hui [1 ]
Fan, Jie [1 ]
Ahn, Ji Hae [1 ]
Orpano, Rachel [1 ]
Zhang, Bin [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA
来源：
JOURNAL OF IMMUNOLOGY | 2023年 / 210卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition
    Chen, Xian
    Low, Kwang-Huei
    Alexander, Angela
    Jiang, Yufeng
    Karakas, Cansu
    Hess, Kenneth R.
    Carey, Jason P. W.
    Bui, Tuyen N.
    Vijayaraghavan, Smruthi
    Evans, Kurt W.
    Yi, Min
    Ellis, D. Christian
    Cheung, Kwok-Leung
    Ellis, Ian O.
    Fu, Siqing
    Meric-Bernstam, Funda
    Hunt, Kelly K.
    Keyomarsi, Khandan
    CLINICAL CANCER RESEARCH, 2018, 24 (24) : 6594 - 6610
  • [2] Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
    Jin, Juan
    Fang, Hehui
    Yang, Fang
    Ji, Wenfei
    Guan, Nan
    Sun, Zijia
    Shi, Yaqin
    Zhou, Guohua
    Guan, Xiaoxiang
    NEOPLASIA, 2018, 20 (05): : 478 - 488
  • [3] POTENTIAL OF TARGETING WEE1 AS THERAPY IN THE MANAGEMENT OF TRIPLE NEGATIVE BREAST CANCER.
    Morrison, G.
    Wang, J.
    Wang, F.
    Geeleher, P.
    Huang, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S83 - S83
  • [4] WEE1 Dependency and Pejorative Prognostic Value in Triple-Negative Breast Cancer
    de Nonneville, Alexandre
    Finetti, Pascal
    Birnbaum, Daniel
    Mamessier, Emilie
    Bertucci, Francois
    ADVANCED SCIENCE, 2021, 8 (17)
  • [5] POTENTIAL OF TARGETING WEE1 AS THERAPY IN THE MANAGEMENT OF TRIPLE NEGATIVE BREAST CANCER.
    Morrison, G.
    Wang, J.
    Wang, F.
    Geeleher, P.
    Huang, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S6 - S6
  • [6] Wee1 inhibition enhances the anti-tumor effects of capecitabine in preclinical models of triple negative breast cancer
    Pitts, Todd M.
    Simmons, Dennis M.
    Dailey, Kyrie
    Bagby, Stacey M.
    Hartman, Sarah J.
    Yacob, Betelehem W.
    Gittleman, Brian
    Tentler, John J.
    Cittely, Diana
    Ormond, D. Ryan
    Messersmith, Wells A.
    Eckhardt, S. Gail
    Diamond, Jennifer R.
    CANCER RESEARCH, 2020, 80 (04)
  • [7] Rational combination of Wee1 and BCL-2 inhibition in preclinical models of triple-negative breast cancer
    Simmons, D. M.
    Tse, T. E.
    Dailey, K.
    Hartman, S. J.
    Bagsby, S.
    Pitts, T. M.
    Tentler, J. J.
    Diamond, J. R.
    CANCER RESEARCH, 2019, 79 (04)
  • [8] Expression Levels and Clinical Significance of WEE1 and mTOR in Triple-Negative Breast Cancer
    Zu, Caixia
    Chang, Donghua
    Shu, Yile
    Wu, Leijuan
    Liu, Fei
    INDIAN JOURNAL OF SURGERY, 2024, : 142 - 149
  • [9] Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer
    Pitts, Todd M.
    Simmons, Dennis M.
    Bagby, Stacey M.
    Hartman, Sarah J.
    Yacob, Betelehem W.
    Gittleman, Brian
    Tentler, John J.
    Cittelly, Diana
    Ormond, D. Ryan
    Messersmith, Wells A.
    Eckhardt, S. Gail
    Diamond, Jennifer R.
    CANCERS, 2020, 12 (03)
  • [10] Targeting WEE1 Kinase in Cancer
    Matheson, Christopher J.
    Backos, Donald S.
    Reigan, Philip
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2016, 37 (10) : 872 - 881
12345